Core--Protocol specific research support

$0P30FY2000CANIH

University Of Nebraska Medical Center, Omaha NE

Investigators

Linked publications & trials

Paper 39684445 Paper 39678719 Paper 39605468 Paper 39580490 Paper 39573886 Paper 39456534 Paper 39450301 Paper 39436320 Paper 39420209 Paper 39386613 Paper 39386448 Paper 39384153 Paper 39339419 Paper 39224072 Paper 39219576 Paper 39151112 Paper 39141488 Paper 39130636 Paper 39125017 Paper 39110778 Paper 39107463 Paper 39080401 Paper 39013847 Paper 38974465 Paper 38969056 Paper 38946943 Paper 38900505 Paper 38853862 Paper 38847506 Paper 38775157 Paper 38770637 Paper 38733583 Paper 38712184 Paper 38704607 Paper 38687198 Paper 38683788 Paper 38672426 Paper 38617282 Paper 38603627 Paper 38547055 Paper 38542184 Paper 38514303 Paper 38482976 Paper 38445903 Paper 38437585 Paper 38429478 Paper 38421730 Paper 38405788 Paper 38397158 Paper 38394685 Paper 38388663 Paper 38381773 Paper 38373465 Paper 38347948 Paper 38303112 Paper 38284649 Paper 38278978 Paper 38258111 Paper 38227647 Paper 38180583 Paper 38123510 Paper 38110836 Paper 38095415 Paper 38093839 Paper 38067133 Paper 38010872 Paper 38008263 Paper 38000343 Paper 37961833 Paper 37940068 Paper 37931287 Paper 37928187 Paper 37928181 Paper 37874141 Paper 37815870 Paper 37777555 Paper 37759490 Paper 37756579 Paper 37747235 Paper 37722652 Paper 37689825 Paper 37628698 Paper 37626854 Paper 37614231 Paper 37478915 Paper 37474760 Paper 37466902 Paper 37454130 Paper 37357909 Paper 37283496 Paper 37243489 Paper 37074924 Paper 37062329 Paper 37037900 Paper 36997106 Paper 36982565 Paper 36967186 Paper 36963650 Paper 36923592 Paper 36872587

Abstract

Description: Protocol specific research support is to provide direct assistance for investigator-initiated clinical trials that are reviewed by the institutional protocol review and monitoring system. The application states that 418 patients were entered into clinical trials during the past year, with 114 to national clinical trials and 304 to institutional trials. The Center is committed to developmental Phase I and pilot clinical trials, and currently there are 22 pilot studies and Phase I studies active. Sixteen of these are therapeutic. Three are Phase I, and nine are pilot institutional investigator initiated trials. In addition, several investigators are anticipating design and implementation of pilot trials.

View original record on NIH RePORTER →